Jennifer Ligibel, PhD profile page

Dr. Jennifer Ligibel is a professor at Harvard Medical School and a senior physician in the Breast Oncology Center at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on the impact of energy balance factors, such as physical activity and body weight, upon cancer risk and outcomes. She has conducted more than a dozen randomized trials evaluating the impact of exercise and weight loss interventions on endpoints such as cardiorespiratory fitness, biomarkers associated with cancer risk and outcomes, body composition, and quality of life in cancer patients and survivors. This work has culminated in the design and implementation of the Breast Cancer Weight Loss (BWEL) Trial, the only fully powered Phase 3 clinical trial designed to test the impact of a weight loss intervention on invasive disease-free survival in women with early-stage breast cancer and obesity.